扭亏为盈 华邦健康预计2025年实现净利润最高7.3亿元

Core Viewpoint - Huabang Health is expected to achieve a net profit attributable to shareholders of 660 million to 730 million yuan in 2025, marking a turnaround from losses in the previous year [2]. Group 1: Company Overview - Huabang Health was established in 1992 and focuses on clinical skin medications and skin health [2]. - The company has developed a model of independent growth with three listed subsidiaries in the fields of agriculture, new materials, and tourism [2]. - The business scope includes five major areas: pharmaceuticals, medical services, agriculture, new materials, and tourism [2]. Group 2: Performance and Growth - The agricultural and new materials sectors have shown signs of recovery, leading to improved overall performance through market expansion and cost management [2]. - The pharmaceutical and tourism sectors have also experienced steady growth, contributing to the overall performance increase of the company [2].